Significance of alpha 9 beta 1 and alpha v beta 6 integrin expression in breast carcinoma.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Breast Cancer

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 11029766
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structural requirements for alpha 9 beta 1-mediated adhesion and migration to thrombin-cleaved osteopontin.

  1998cited by this paper
• Identification of the ligand binding site for the integrin alpha9 beta1 in the third fibronectin type III repeat of tenascin-C.

  1998cited by this paper
• Expression of the alpha9beta1 integrin in human colonic epithelial cells: resurgence of the fetal phenotype in a subset of colon cancers and adenocarcinoma cell lines.

  1998cited by this paper
• A novel peptide, PLAEIDGIELTY, for the targeting of α9β1‐integrins

  1998cited by this paper
• Changes in the expression of alpha v integrins in oral squamous cell carcinomas.

  1997cited by this paper
• Upregulation of alpha 9 integrin and tenascin during epithelial regeneration after debridement in the cornea.

  1997cited by this paper
• Integrin alpha v beta 6 enhances coxsackievirus B1 lytic infection of human colon cancer cells.

  1997cited by this paper
• Roles of airway epithelial integrins in health and disease. The Parker B. Francis Lectureship.

  1996cited by this paper
• Osteopontin N-terminal domain contains a cryptic adhesive sequence recognized by alpha9beta1 integrin.

  1996cited by this paper
• Keratinocytes in human wounds express alpha v beta 6 integrin.

  1996cited by this paper
• Expression of integrin subunits in the human infant breast correlates with morphogenesis and differentiation

  1995cited by this paper
• Adhesion systems in normal breast and in invasive breast carcinoma.

  1995cited by this paper
• Expression of the integrin subunit alpha 9 in the murine embryo.

  1995cited by this paper
• Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer.

  1995cited by this paper
• Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling.

  1995cited by this paper
• Distribution of integrins alpha v beta 6 and alpha 9 beta 1 and their known ligands, fibronectin and tenascin, in human airways.

  1995cited by this paper
• Role of the integrin alpha v beta 6 in cell attachment to fibronectin. Heterologous expression of intact and secreted forms of the receptor.

  1994cited by this paper
• The integrin alpha 9 beta 1 mediates cell attachment to a non-RGD site in the third fibronectin type III repeat of tenascin.

  1994cited by this paper
• Multiple integrins mediate cell attachment to cytotactin/tenascin.

  1993cited by this paper
• Altered integrin expression in adenocarcinoma of the breast. Analysis by in situ hybridization.

  1993cited by this paper
• Restricted distribution of integrin beta 6 mRNA in primate epithelial tissues.

  1993cited by this paper
• Loss of VLA‐2 Collagen Receptor in Breast Carcinoma, Facilitating Invasion and Metastasis

  1993cited by this paper
• Sequence and tissue distribution of the integrin alpha 9 subunit, a novel partner of beta 1 that is widely distributed in epithelia and muscle [published erratum appears in J Cell Biol 1994 Feb;124(3):395]

  1993cited by this paper
• A role of VLA‐6 laminin receptor in invasion of breast carcinoma

  1993cited by this paper
• Distribution of laminin, type IV collagen and fibronectin in the invasive component of breast carcinoma

  1993cited by this paper
• Integrins and their accessory adhesion molecules in mammary carcinomas: loss of polarization in poorly differentiated tumors.

  1992cited by this paper
• Changes in expression of alpha 6/beta 4 integrin heterodimer in primary and metastatic breast cancer.

  1992cited by this paper
• Alteration of stromal protein and integrin expression in breast—a marker of premalignant change?

  1992cited by this paper
• Characterization of the integrin alpha v beta 6 as a fibronectin-binding protein.

  1992cited by this paper
• Integrins: versatility, modulation, and signaling in cell adhesion.

  1992cited by this paper
• Immunohistochemical localization of integrins in the normal, hyperplastic, and neoplastic breast. Correlations with their functions as receptors and cell adhesion molecules.

  1991cited by this paper
• Co‐ordinate expression of the alpha‐6 integrin laminin receptor sub‐unit and laminin in breast cancer

  1991cited by this paper
• Low expression of beta 1, alpha 2 and alpha 3 subunits of VLA integrins in malignant mammary tumours.

  1991cited by this paper
• Complete amino acid sequence of a novel integrin beta subunit (beta 6) identified in epithelial cells using the polymerase chain reaction.

  1990cited by this paper
• Expression of ERBB2 in human gastric carcinomas: relationship between p185ERBB2 expression and the gene amplification.

  1990cited by this paper
• Decreased expression of integrin adhesive protein receptors in adenocarcinoma of the breast.

  1990cited by this paper
• Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

  1981cited by this paper
• Histological Grading and Prognosis in Breast Cancer

  1957cited by this paper

• Targeting Matrix Stiffness and Mechanotransduction in Breast Cancer: Implications for Emerging Therapies

  2026cites this paper
• Multivalent DNA Origami Enables Single-Molecule Dissection of Integrin αvβ6–Receptor Tyrosine Kinase Crosstalk in Cancer Biology

  2025cites this paper
• TGFβ-mediated MMP13 secretion drives myoepithelial cell dependent breast cancer progression

  2023cites this paper
• Targeting integrin αvβ6 with gallium-68 tris (hydroxypyridinone) based PET probes

  2022cites this paper
• Integrin Alpha v Beta 6 (αvβ6) and Its Implications in Cancer Treatment

  2022cites this paper
• The fibrillin‐1 RGD motif posttranscriptionally regulates ERK1/2 signaling and fibroblast proliferation via miR‐1208

  2021cites this paper
• Receptor-Mediated Targeted Delivery of Surface-ModifiedNanomedicine in Breast Cancer: Recent Update and Challenges

  2021cites this paper
• Integrin-α9β1 as a Novel Therapeutic Target for Refractory Diseases: Recent Progress and Insights

  2021cites this paper
• SFRP1 in Skin Tumor Initiation and Cancer Stem Cell Regulation with Potential Implications in Epithelial Cancers

  2019cites this paper
• Major Qualifying Projects ( All Years ) Major Qualifying Projects April 2006 Alphav Beta 6 Integrin Expression in Inflamed & Malignant Prostate

  2019cites this paper
• Comparison of the RGD Motif–Containing αvβ6 Integrin–Binding Peptides SFLAP3 and SFITGv6 for Diagnostic Application in HNSCC

  2018cites this paper
• Integrin expression and glycosylation patterns regulate cell-matrix adhesion and alter with breast cancer progression.

  2018cites this paper
• Characterisation of targeted imaging and theranostic agents for cancer and fibrosis

  2018cites this paper
• Comparative Study of the Novel RGD Motif-containing αvβ6 Integrin Binding Peptides SFLAP3 and SFITGv6 for Diagnostic Application in HNSCC

  2018cites this paper
• Exploring the Role of RGD-Recognizing Integrins in Cancer

  2017cites this paper
• The traditional Chinese medicine Achyranthes bidentata and our de novo conception of its metastatic chemoprevention: from phytochemistry to pharmacology

  2017cites this paper
• In Vivo PET Imaging of the Cancer Integrin αvβ6 Using 68Ga-Labeled Cyclic RGD Nonapeptides

  2017cites this paper
• Integrin β6 acts as an unfavorable prognostic indicator and promotes cellular malignant behaviors via ERK-ETS1 pathway in pancreatic ductal adenocarcinoma (PDAC)

  2016cites this paper
• Integrin β6 serves as an immunohistochemical marker for lymph node metastasis and promotes cell invasiveness in cholangiocarcinoma

  2016cites this paper
• Integrin αvβ5 as a biomarker for the assessment of non‐small cell lung cancer metastasis and overall survival

  2015cites this paper
• Pathophysiology of fistula formation in Crohn's disease.

  2014cites this paper
• αvβ6 Expression in myoepithelial cells: a novel marker for predicting DCIS progression with therapeutic potential.

  2014cites this paper
• Targeting of the β6 gene to suppress degradation of ECM via inactivation of the MAPK pathway in breast adenocarcinoma cells

  2014cites this paper
• Integrins: players in cancer progression and targets in cancer therapy

  2014cites this paper
• In vitro and in vivo evaluation of the effects of aluminum [¹⁸F]fluoride radiolabeling on an integrin αvβ₆-specific peptide.

  2014cites this paper
• Molecular imaging of integrin αvβ6 expression in living subjects.

  2014cites this paper
• Dual inhibition of &agr;V integrins and Src kinase activity as a combination therapy strategy for colorectal cancer

  2013cites this paper
• Comparing the expression of integrins αvβ3, αvβ5, αvβ6, αvβ8, fibronectin and fibrinogen in human brain metastases and their corresponding primary tumors.

  2013cites this paper
• A Liposomal Drug Platform Overrides Peptide Ligand Targeting to a Cancer Biomarker, Irrespective of Ligand Affinity or Density

  2013cites this paper
• Stromal cell-derived factor-1 (SDF-1) enhances cells invasion by αvβ6 integrin-mediated signaling in ovarian cancer

  2013cites this paper
• Altered Microenvironment Promotes Progression of Preinvasive Breast Cancer: Myoepithelial Expression of αvβ6 Integrin in DCIS Identifies High-risk Patients and Predicts Recurrence

  2013cites this paper
• Elevated expression of integrin αv and β5 subunit in laryngeal squamous-cell carcinoma associated with lymphatic metastasis and angiogenesis.

  2013cites this paper
• A human monoclonal antibody 264RAD targeting αvβ6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivo

  2013cites this paper
• From phage display to nanoparticle delivery: functionalizing liposomes with multivalent peptides improves targeting to a cancer biomarker.

  2013cites this paper
• Integrin αvβ6 as a novel marker for diagnosis and metastatic potential of thyroid carcinoma

  2013cites this paper
• Binding of αvβ1 and αvβ6 integrins to tenascin-C induces epithelial–mesenchymal transition-like change of breast cancer cells

  2013cites this paper
• The newcomer in the integrin family: integrin α9 in biology and cancer.

  2012cites this paper
• Targeting αV-integrins decreased metastasis and increased survival in a nude rat breast cancer brain metastasis model

  2012cites this paper
• Matched rabbit monoclonal antibodies against αv-series integrins reveal a novel αvβ3-LIBS epitope, and permit routine staining of archival paraffin samples of human tumors

  2012cites this paper
• Integrin alpha9 (ITGA9) expression and epigenetic silencing in human breast tumors

  2011cites this paper
• Synthesis and biological evaluation of a peptide-paclitaxel conjugate which targets the integrin αvβ₆.

  2011cites this paper
• Why Integrin as a Primary Target for Imaging and Therapy

  2011cites this paper
• The αvβ6 Integrin in cancer

  2011cites this paper
• Clinical and functional significance of α9β1 integrin expression in breast cancer: a novel cell‐surface marker of the basal phenotype that promotes tumour cell invasion

  2011cites this paper
• PKC promotes the migration of colon cancer cells by regulating the internalization and recycling of integrin αvβ6.

  2011cites this paper
• Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease

  2010cites this paper
• MRI-visible micellar nanomedicine for targeted drug delivery to lung cancer cells.

  2010cites this paper
• Oxidative Stress Induced Mechanisms in the Progression of Periodontal Diseases and Cancer: A Common Approach to Redox Homeostasis?

  2010cites this paper
• Transductional retargeting of human adenovirus type 5 to ανβ6 integrin for cancer gene therapy

  2009cites this paper
• Function of β1 Integrin in Oral Epithelia and Tooth Bud Morphogenesis

  2009cites this paper
• Defining the Role of Integrin αvβ6 in Cancer

  2009cites this paper
• Defining the role of integrin alphavbeta6 in cancer.

  2009cites this paper
• Synthesis and characterization of a high-affinity αvβ6-specific ligand for in vitro and in vivo applications

  2009cites this paper
• Signaling and regulatory mechanisms of integrin alphavbeta6 on the apoptosis of colon cancer cells.

  2008cites this paper
• The Role of Integrins in Cancer and the Development of Anti-Integrin Therapeutic Agents for Cancer Therapy

  2008cites this paper
• Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism.

  2008cites this paper
• Overexpression of the αvβ6 Integrin in Endometrial Cancer

  2008cites this paper
• Peptide-targeted polyglutamic acid doxorubicin conjugates for the treatment of alpha(v)beta(6)-positive cancers.

  2008cites this paper
• Engineering a single-chain Fv antibody to alpha v beta 6 integrin using the specificity-determining loop of a foot-and-mouth disease virus.

  2008cites this paper
• Integrin alphanvbeta6 acts as a prognostic indicator in gastric carcinoma.

  2008cites this paper
• αv Integrin-Targeted Immunoconjugates Regress Established Human Tumors in Xenograft Models

  2007cites this paper
• Overexpression of the αvβ6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival

  2007cites this paper
• CNTO 95, a fully human anti αv integrin antibody, inhibits cell signaling, migration, invasion, and spontaneous metastasis of human breast cancer cells

  2007cites this paper
• Constitutively Activated Stat3 Induces Tumorigenesis and Enhances Cell Motility of Prostate Epithelial Cells through Integrin β6

  2007cites this paper
• Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival.

  2007cites this paper
• A peptide selected by biopanning identifies the integrin alphavbeta6 as a prognostic biomarker for nonsmall cell lung cancer.

  2007cites this paper
• Alphavbeta6 integrin in wound healing and cancer of the oral cavity.

  2006cites this paper
• Cyclooxygenase-2 inhibition suppresses alphavbeta6 integrin-dependent oral squamous carcinoma invasion.

  2006cites this paper
• Association of platelet glycoprotein Ia polymorphism with minor increase of risk for oral cancer.

  2006cites this paper
• Matrix metalloproteinases (MMPs) in oral carcinomas

  2005cites this paper
• The alphaVbeta6 integrin as a novel molecular target for colorectal cancer.

  2005cites this paper
• Characterization of integrin β6 and thrombospondin‐1 double‐null mice

  2005cites this paper
• OVEREXPRESS ION OF THE αVβ6 INTEGR IN IN CERV ICAL SQUAMOUS CELL CARC INOMA I S A PROGNOST I C FACTOR FOR DECREASED SURV IVAL

  2005cites this paper
• Expression of cell adhesion molecules in oesophageal carcinoma and its prognostic value

  2005cites this paper
• Immunohistochemical screening for β6‐integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up‐regulation in pancreatic ductal adenocarcinomas in vivo and in vitro

  2004cites this paper
• Expression and localization of αvβ6 integrin in extraplacental fetal membranes: possible role in human parturition

  2004cites this paper
• Modulation of the urokinase-type plasminogen activator receptor by the beta6 integrin subunit.

  2004cites this paper
• Immunohistochemical screening for beta6-integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up-regulation in pancreatic ductal adenocarcinomas in vivo and in vitro.

  2004cites this paper
• The Integrin Cytoplasmic-tail Motif EKQKVDLSTDC Is Sufficient to Promote Tumor Cell Invasion Mediated by Matrix Metalloproteinase (MMP)-2 or MMP-9*

  2004cites this paper
• Alphavbeta6-Fyn signaling promotes oral cancer progression.

  2003cites this paper
• Immunohistochemical analysis of alphavbeta5 and alphavbeta6 integrins in the endometrium and endometriosis.

  2002cites this paper
• Direct integrin alphavbeta6-ERK binding: implications for tumour growth.

  2002cites this paper
• Alpha(v)beta(6) integrin-A marker for the malignant potential of epithelial ovarian cancer.

  2002cites this paper
• Integrin αvβ6-associated ERK2 mediates MMP-9 secretion in colon cancer cells

  2002cites this paper
• αvβ6 Integrin-A Marker for the Malignant Potential of Epithelial Ovarian Cancer

  2002cites this paper
• Integrin expression in colon cancer cells is regulated by the cytoplasmic domain of the β6 integrin subunit

  2002cites this paper
• Binding of TGF-β1 latency-associated peptide (LAP) to αvβ6 integrin modulates behaviour of squamous carcinoma cells

  2002cites this paper
• Immunohistochemical Analysis of v 5 and v 6 Integrins in the Endometrium and Endometriosis

  2002cites this paper
• Role of the alpha(v)beta6 integrin in human oral squamous cell carcinoma growth in vivo and in vitro.

  2001cites this paper